Key points are not available for this paper at this time.
Although these treatments are at various stages of clinical development, they represent a new frontier in expanding the treatment options available for individuals with TRD, as well as contributing to a better understanding the neurobiology of depressive disorders.
Kennedy et al. (Mon,) studied this question.